MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202517018580 A) filed by Mindset Pharma Inc., Toronto, on March 3, for 'indoline derivatives as serotonergic agents useful for the treatment of disorders related thereto.'
Inventor(s) include Slassi, Abdelmalik.
The application for the patent was published on April 25, under issue no. 17/2025.
According to the abstract released by the Intellectual Property India: "The present application relates to methods of activating serotonin receptors in a cell using indoline derivatives of general Formula (I) or a pharmaceutically acceptable salt, solvate and/or prodrug thereof, as well as to treating diseases, disorders or conditions by activation of a serot...